img
Deletions in VANGL1 are a risk factor for antibody-mediated kidney disease   
Yazarlar
Simon H. Jiang
The John Curtin School of Medical Research, Australia
Dr. Öğr. Üyesi Sevcan MERCAN Dr. Öğr. Üyesi Sevcan MERCAN
Kafkas Üniversitesi, Türkiye
Ilenia Papa
The John Curtin School of Medical Research, Australia
Max Moldovan
University of South Australia, Australia
Giles D. Walters
Canberra Hospital, Australia
Mark Koina
Canberra Hospital, Australia
Mitali Fadia
Canberra Hospital, Australia
Maurice Stanley
The John Curtin School of Medical Research, Australia
Tom Lea-Henry
The John Curtin School of Medical Research, Australia
Amelia Cook
The John Curtin School of Medical Research, Australia
Julia Ellyard
The John Curtin School of Medical Research, Australia
Brendan McMorran
The John Curtin School of Medical Research, Australia
Madhivanan Sundaram
Royal Darwin Hospital, Australia
Russell Thomson
Western Sydney University, Australia
Pablo F. Canete
The John Curtin School of Medical Research, Australia
Wendy Hoy
The University of Queensland, Australia
Holly Hutton
Monash University, Australia
Monika Srivastava
The John Curtin School of Medical Research, Australia
Kathryn McKeon
The John Curtin School of Medical Research, Australia
Iñigo de la Rúa Figueroa
Hospital de Gran Canaria Dr. Negrin, Spain
Ricard Cervera
Hospital Clínic de Barcelona, Spain
Raquel Faria
Centro Hospitalar Universitário de Santo António, Portugal
Sandra D'Alfonso
Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, Italy
Mariele Gatto
Università degli Studi di Padova, Italy
Vicki Athanasopoulos
The John Curtin School of Medical Research, Australia
Matthew Field
James Cook University, Australia
John Mathews
Melbourne School of Population and Global Health, Australia
Eun Cho
The John Curtin School of Medical Research, Australia
Thomas D. Andrews
The John Curtin School of Medical Research, Australia
A. Richard Kitching
Monash University, Australia
Matthew C. Cook
Canberra Hospital, Australia
Marta Alarcon Riquelme
Centro Pfizer – Universidad de Granada – Junta de Andalucía de Genómica e Investigación Oncológica (, Spain
Melanie Bahlo
Walter and Eliza Hall Institute of Medical Research, Australia
Carola G. Vinuesa
The John Curtin School of Medical Research, Australia
Özet
We identify an intronic deletion in VANGL1 that predisposes to renal injury in high risk populations through a kidney-intrinsic process. Half of all SLE patients develop nephritis, yet the predisposing mechanisms to kidney damage remain poorly understood. There is limited evidence of genetic contribution to specific organ involvement in SLE.1,2 We identify a large deletion in intron 7 of Van Gogh Like 1 (VANGL1), which associates with nephritis in SLE patients. The same deletion occurs at increased frequency in an indigenous population (Tiwi Islanders) with 10-fold higher rates of kidney disease compared with non-indigenous populations. Vangl1 hemizygosity in mice results in spontaneous IgA and IgG deposition within the glomerular mesangium in the absence of autoimmune nephritis. Serum transfer into B cell-deficient Vangl1+/− mice results in mesangial IgG deposition indicating that Ig deposits occur in a kidney-intrinsic fashion in the absence of Vangl1. These results suggest that Vangl1 acts in the kidney to prevent Ig deposits and its deficiency may trigger nephritis in individuals with SLE.
Anahtar Kelimeler
antibody | autoimmune | chronic kidney disease | genetic | glomerulonephritis | immunoglobulin | lupus nephritis
Makale Türü Özgün Makale
Makale Alt Türü SCOPUS dergilerinde yayımlanan tam makale
Dergi Adı Cell Reports Medicine
Dergi ISSN 2666-3791
Makale Dili İngilizce
Basım Tarihi 12-2021
Cilt No 2
Sayı 12
Doi Numarası 10.1016/j.xcrm.2021.100475
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
SCOPUS 5
Deletions in VANGL1 are a risk factor for antibody-mediated kidney disease

Paylaş